chr11-118472663-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001197104.2(KMT2A):c.1504G>A(p.Glu502Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00583 in 1,612,902 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 10 hom., cov: 31)
Exomes 𝑓: 0.0058 ( 89 hom. )
Consequence
KMT2A
NM_001197104.2 missense
NM_001197104.2 missense
Scores
2
6
9
Clinical Significance
Conservation
PhyloP100: 3.45
Publications
14 publications found
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
- Wiedemann-Steiner syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0042158663).
BP6
Variant 11-118472663-G-A is Benign according to our data. Variant chr11-118472663-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00584 (882/151030) while in subpopulation NFE AF = 0.0058 (393/67802). AF 95% confidence interval is 0.00532. There are 10 homozygotes in GnomAd4. There are 511 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 882 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2A | NM_001197104.2 | c.1504G>A | p.Glu502Lys | missense_variant | Exon 3 of 36 | ENST00000534358.8 | NP_001184033.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00584 AC: 882AN: 150912Hom.: 10 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
882
AN:
150912
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00663 AC: 1662AN: 250866 AF XY: 0.00637 show subpopulations
GnomAD2 exomes
AF:
AC:
1662
AN:
250866
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00583 AC: 8522AN: 1461872Hom.: 89 Cov.: 34 AF XY: 0.00553 AC XY: 4018AN XY: 727240 show subpopulations
GnomAD4 exome
AF:
AC:
8522
AN:
1461872
Hom.:
Cov.:
34
AF XY:
AC XY:
4018
AN XY:
727240
show subpopulations
African (AFR)
AF:
AC:
24
AN:
33480
American (AMR)
AF:
AC:
87
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
12
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
AC:
2237
AN:
53400
Middle Eastern (MID)
AF:
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
5846
AN:
1112012
Other (OTH)
AF:
AC:
315
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
552
1103
1655
2206
2758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00584 AC: 882AN: 151030Hom.: 10 Cov.: 31 AF XY: 0.00694 AC XY: 511AN XY: 73628 show subpopulations
GnomAD4 genome
AF:
AC:
882
AN:
151030
Hom.:
Cov.:
31
AF XY:
AC XY:
511
AN XY:
73628
show subpopulations
African (AFR)
AF:
AC:
39
AN:
41118
American (AMR)
AF:
AC:
35
AN:
15058
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5162
South Asian (SAS)
AF:
AC:
0
AN:
4746
European-Finnish (FIN)
AF:
AC:
403
AN:
10382
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
393
AN:
67802
Other (OTH)
AF:
AC:
9
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
19
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
48
ExAC
AF:
AC:
756
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:6
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
KMT2A: BS2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
May 03, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Feb 17, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:2
Dec 02, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;L
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N;.
REVEL
Benign
Sift
Pathogenic
.;D;D;D;.
Sift4G
Pathogenic
.;T;T;T;.
Vest4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.